Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/019170 stock hub

KRX/019170 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KRX/019170is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
600.1B
Korea Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
KRX/019170
In the news

Latest news · KRX/019170

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 9.8P50 17.1P75 31.9
Trailing P/E66.9
P25 12P50 23.1P75 39.5
ROE3.2
P25 -17.1P50 0.7P75 8.5
ROIC5.6
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KRX/019170 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
218
Groups with data
11
Currency
KRW
Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
South Korea
Country code
KR
Employees
809
Enterprise value
KRW 585.2B
Exchange
Korea Stock Exchange
Financial currency
KRW
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
KR7019170000
Last refreshed
2026-05-10
Market cap
KRW 600.1B
Price
KRW 11,510
Price currency
KRW
Rev Per Employee
290,087,334.02x
Sector
Healthcare
Sic
2834
Symbol
krx/019170
Website
https://shinpoong.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
1.47%
EV Earnings
66.31x
EV/EBIT
41.05x
EV/EBITDA
22.82x
EV/FCF
42.48x
EV/Sales
2.49x
FCF yield
2.3%
P/B ratio
2.22x
P/E ratio
66.92x
P/S ratio
2.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
6.07%
EBITDA Margin
10.93%
FCF margin
5.87%
Gross margin
43.75%
Gross Profit
KRW 102.7B
Gross Profit Growth
25.51%
Gross Profit Growth Q
29.02%
Gross Profit Growth3 Y
9.61%
Gross Profit Growth5 Y
6.05%
Net Income
KRW 8.8B
Net Income Growth Quarters
8%
Net Income Growth Years
2%
Net Income Growth5 Y
12.02%
Pretax Margin
3.6%
Profit Margin
3.76%
Profit Per Employee
KRW 10.9M
Profitable Years
1
ROA
2.57
Roa5y
-3.29
ROCE
4.99
ROE
3.17
Roe5y
-7
ROIC
5.56
Roic5y
-7.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

21
MetricValue
Cagr10y
4.93%
Cagr15y
8.4%
Cagr1y
54.75%
Cagr20y
10.07%
Cagr3y
-14.41%
Cagr5y
-29.12%
Div CAGR10
6.91%
Div CAGR3
25.99%
Div CAGR5
14.87%
EPS Growth Quarters
8
EPS Growth Years
2
EPS Growth5 Y
11.59
FCF Growth5 Y
-4.57%
OCF Growth10 Y
3.64%
OCF Growth5 Y
-2.97%
Revenue Growth
6.15x
Revenue Growth Q
5.03x
Revenue Growth Quarters
8x
Revenue Growth Years
2x
Revenue Growth3 Y
3.89x
Revenue Growth5 Y
3.48x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
KRW 0.68
Assets
KRW 352.5B
Cash
KRW 71.5B
Current Assets
KRW 206.7B
Current Liabilities
KRW 66.9B
Debt
KRW 55.9B
Debt EBITDA
KRW 2.18
Debt Equity
KRW 0.21
Debt FCF
KRW 4.05
Equity
KRW 270.7B
Interest Coverage
5.3
Liabilities
KRW 81.7B
Long Term Assets
KRW 145.7B
Long Term Liabilities
KRW 14.8B
Net Cash
KRW 15.7B
Net Cash By Market Cap
KRW 2.61
Net Cash Growth
739.66%
Net Debt EBITDA
KRW -0.61
Net Debt Equity
KRW -0.06
Net Debt FCF
KRW -1.14
Tangible Book Value
KRW 264.9B
Tangible Book Value Per Share
KRW 5,163
WACC
10.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.09
Inventory Turnover
2.32
Net Working Capital
KRW 112.7B
Quick ratio
2.16
Working Capital
KRW 139.8B
Working Capital Turnover
KRW 1.85

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-0.37%
Dividend per share
KRW 0
Last Dividend
KRW 100

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
61.8%
1Y total return
54.7%
200-day SMA
12,821.8
3Y total return
-37.31%
50-day SMA
11,154.4
50-day SMA vs 200-day SMA
50under200
5Y total return
-82.1%
All Time High
214,000
All Time High Change
-94.62%
All Time High Date
2020-09-21
All Time Low
58.13
All Time Low Change
19,699.43%
All Time Low Date
1998-09-23
ATR
598.3
Beta
1.27
Beta1y
0.42
Beta2y
0.64
Ch YTD
-18.02
High
12,000
High52
20,500
High52 Date
2025-06-19
High52ch
-43.85%
Low
11,250
Low52
7,210
Low52 Date
2025-05-12
Low52ch
59.64%
Ma50ch
3.19%
Price vs 200-day SMA
-10.23%
RSI
50.93
RSI Monthly
44.51
RSI Weekly
46.27
Sharpe ratio
0.82x
Sortino ratio
1.82
Total Return
-0.37%
Tr YTD
-18.02
Tr15y
235.47%
Tr1m
12.29%
Tr1w
0.61%
Tr3m
-8.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
KRW 14.3B
Operating Income Growth5 Y
12.98
Operating margin
6.07

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
33,440,860%
Net Borrowing
3,704,977,330
Shares Insiders
8.72%
Shares Institutions
2.82%
Shares Out
50,695,791
Shares Qo Q
-0.27%
Shares Yo Y
0.37%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

64
MetricValue
Adjusted FCF
KRW 13.8B
Average Volume
663,148.35x
Bv Per Share
5,262.5
CAPEX
KRW -3.5B
Ch10y
61.66
Ch15y
220.6
Ch1m
12.29
Ch1w
0.61
Ch1y
54.7
Ch20y
485.2
Ch3m
-8.8
Ch3y
-37.31
Ch5y
-82.1
Ch6m
-17.37
Change
4.35%
Change From Open
-4
Close
11,030
Days Gap
8.7
Depreciation Amortization
11,392,767,000
Dollar Volume
6,865,208,560
Earnings Date
2026-05-14
EBIT
KRW 14.3B
EBITDA
KRW 25.6B
EPS
KRW 172
F Score
7
FCF
KRW 13.8B
FCF EV Yield
2.35x
FCF Per Share
KRW 272
Financing CF
3,704,977,320
Fiscal Year End
December
Founded
1,962
Graham Number
4512.87237
Graham Upside
-60.79
Income Tax
KRW 62.5M
Investing CF
-14,705,675,920
Is Primary Listing
1
Last Earnings Date
2025-11-14
Last Report Date
2025-12-31
Last Split Date
2014-12-29
Last Split Type
Forward
Lynch Fair Value
KRW 2,068
Lynch Upside
-82.04
Ma150
12,795.7
Ma150ch
-10.05%
Ma20
11,535
Ma20ch
-0.22%
Net CF
5,446,762,370
Next Earnings Date
2026-05-14
Open
11,990
P FCF Ratio
43.56
P OCF Ratio
34.78
Position In Range
34.67
Ppne
108,727,653,570
Price Date
2026-05-08
Price EBITDA
KRW 23.4
Ptbv Ratio
2.27
Relative Volume
0.9x
Revenue
234,680,653,220x
Tax By Revenue
0.03x
Tax Rate
0.74%
Tr20y
581.43%
Tr6m
-17.37%
Volume
596,456
Z Score
5.99
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does KRX/019170 pay a dividend?

Capital-return profile for this ticker.

Performance

KRX/019170 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+54.7%
S&P 500 1Y: n/a
3Y total return
-37.3%
S&P 500 3Y: n/a
5Y total return
-82.1%
S&P 500 5Y: n/a
10Y total return
+61.8%
S&P 500 10Y: n/a
Ownership

Who owns KRX/019170?

Insider, institutional, and short-interest positioning.

Institutional ownership
+2.8%
Share of float held by funds and institutions
Insider ownership
+8.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.4%
Negative means the company is buying back shares.
Technical

KRX/019170 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
50.9
Neutral momentum band
Price vs 200-day MA
-10.2%
50/200-day relationship not available
Beta (5Y)
1.27
More volatile than the market
Sharpe ratio
0.82
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KRX/019170

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/019170 stock rating?

krx/019170 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/019170 analysis?

The full report lives at /stocks/krx/019170/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/019170?

The latest report frames krx/019170 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/019170 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.